Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
/	O
prednisone	O
/	O
nitroglycerin	O
/	O
Cortisone	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
with	O
mild	O
delirium,	B-Delirium
PMHx	O
of	O
CAD	O
(s/p	O
CABG),	O
AS	O
(sp	O
AVR),	O
HTN,	O
CKD,	O
recurrent	O
UTI	B-Urinary_tract_infection
___	O
urinary	O
obstruction	O
and	O
BPH	O
(s/p	O
TURP)	O
who	O
was	O
noted	O
at	O
nursing	O
___	O
to	O
have	O
worsening	O
shortness	O
of	O
breath	O
over	O
the	O
last	O
___	O
days.	O
He	O
had	O
a	O
similar	O
presentation	O
last	O
___.	O
He	O
had	O
labs	O
drawn	O
with	O
elevated	O
potassium	O
5.6,	O
Hct	O
18.8.	O
He	O
was	O
initially	O
to	O
come	O
to	O
___	O
but	O
concern	O
for	O
worsening	O
SOB	O
had	O
ambulance	O
divert	O
to	O
OSH.	O
At	O
___	O
his	O
initial	O
vitals	O
were	O
97.1	O
146/69	O
56	O
32	O
and	O
97%	O
on	O
NRB.	O
He	O
was	O
quickly	O
transitioned	O
to	O
room	O
air.	O
His	O
Hct	O
was	O
17.9	O
and	O
guaiac	O
positive.	O
He	O
was	O
hyperkalemic	O
to	O
6.0	O
with	O
peaked	O
Ts	O
on	O
EKG.	O
He	O
had	O
___	O
with	O
Cr	O
3.8	O
from	O
3.1	O
last	O
month,	O
and	O
fluid	O
overload	O
with	O
trace	O
right	O
pleural	O
effusions	O
on	O
CXR	O
per	O
report.	O
He	O
was	O
ordered	O
for	O
1U	O
PRBCs	O
and	O
had	O
no	O
adjustment	O
made	O
to	O
his	O
potassium.	O
In	O
the	O
ED,	O
initial	O
vs	O
were:	O
99.0	O
49	O
171/71	O
28	O
96%	O
4L.	O
He	O
arived	O
in	O
with	O
1	O
unit	O
pRBCs	O
infusing.	O
He	O
was	O
A&Ox3	B-Delirium
but	O
slow,	O
speaking	O
in	O
full	O
sentences	O
and	O
using	O
some	O
accessory	O
muscles.	O
He	O
received	O
calcium	O
gluconate,	O
10U	O
regular	O
insulin,	O
D50	O
for	O
K	O
6.2.	O
He	O
did	O
not	O
get	O
albuterol	O
or	O
bicarb.	O
He	O
was	O
seen	O
by	O
renal	O
who	O
recommended	O
temporizing	O
measures	O
for	O
hyperK	O
as	O
well	O
as	O
lasix	O
for	O
hyperK	O
and	O
fluid	O
overload.	O
He	O
was	O
given	O
an	O
60mg	O
of	O
lasix	O
and	O
put	O
out	O
at	O
least	O
400cc	O
of	O
urine	O
via	O
foley	O
for	O
pulmonary	O
edema	O
on	O
CXR.	O
He	O
was	O
sating	O
93%	O
on	O
RA	O
and	O
was	O
placed	O
on	O
therapeutic	O
2L	O
NC.	O
On	O
the	O
floor,	O
the	O
patient	O
is	O
sleepy,	O
and	O
complaining	O
of	O
feeling	O
cold.	O
He	O
has	O
no	O
pain.	O
He	O
says	O
he	O
has	O
noted	O
dime	O
sized	O
blood	B-Lower_gastrointestinal_haemorrhage
in	B-Lower_gastrointestinal_haemorrhage
stools.	B-Lower_gastrointestinal_haemorrhage
No	O
hematochezia,	B-Lower_gastrointestinal_haemorrhage
no	O
melena.	B-Upper_gastrointestinal_haemorrhage
Past	O
Medical	O
History:	O
-	O
BPH	O
w/	O
urinary	O
retention	O
and	O
chronic	O
indwelling	O
catheter	O
now	O
s/p	O
Transurethral	O
resection	O
of	O
prostate.	O
-	O
CKD	O
-	O
CAD	O
s/p	O
CABG	O
w/	O
AVR	O
-	O
psychiatric	O
d/o	O
NOS,	O
-	O
hx	O
recurrent	O
UTI	B-Urinary_tract_infection
(requiring	O
2wks	O
course	O
Ertapenem	O
in	O
___	O
and	O
___.	O
-	O
Vitamin	O
D	O
deficiency	O
-	O
GOUT	O
-	O
GERD	O
-	O
HTN	O
-	O
diastrolic	O
CHF	O
with	O
EF	O
55%	O
-	O
Seizure	B-Seizures
disorder	O
Social	O
History:	O
___	O
Family	O
History:	O
Per	O
the	O
patient,	O
no	O
family	O
history	O
of	O
bladder,	O
prostate,	O
or	O
renal	O
disease.	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM:	O
========================	O
General:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress	O
HEENT:	O
Sclera	O
pale,	O
Dry	O
MM,	O
pharynx	O
erythematous	O
Neck:	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
Lungs:	O
Left	O
sided	O
rhonchi,	O
crackles	O
diffusely	O
CV:	O
Bradycardic,	O
regular,	O
healed	O
sternotomy	O
scar	O
Abdomen:	O
soft,	O
non-tender,	O
distended,	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
GU:	O
foley	O
Ext:	O
2+	O
pitting	O
edema	O
to	O
knees	O
DISCHARGE	O
PHYSICAL	O
EXAM:	O
========================	O
VS:	O
98.8	O
125/64	O
69	O
18	O
99	O
RA	O
I/O:	O
___	O
General:	O
Lying	O
comfortably	O
in	O
bed,	O
alert,	O
in	O
NAD.	O
HEENT:	O
PERRL	O
3-->2.	O
EOM	O
intact.	O
Conjunctiva	O
clear.	O
OP	O
clear.	O
Neck:	O
Supple	O
no	O
LAD	O
CV:	O
Grade	O
___	O
harsh	O
systolic	O
murmur	O
over	O
LUSB.	O
Lungs:	O
Expiratory	O
rhonchi	O
throughout	O
lung	O
fields.	O
No	O
wheeze.	O
Faint	O
crackles	O
at	O
bases,	O
moderate	O
aeration.	O
Abdomen:	O
Soft,	O
distended,	O
non-tender,	O
tympanitic	O
to	O
percussion.	O
GU:	O
deferred	O
Ext:	O
WWP,	O
2+	O
DPs,	O
no	O
edema	O
Neuro:	O
A/O	O
x2	O
(does	O
not	O
know	O
date).	O
PERRL.	O
EOM	O
intact.	O
Facial	O
musculature	O
symmetric.	O
Tongue	O
midline.	O
Palate	O
elevates	O
symmetrically.	O
Voice	O
hoarse	O
but	O
without	O
dysarthria.	O
Moving	O
all	O
extremities	O
spontaneously.	O
Skin:	O
bruising	O
at	O
IV	O
sites,	O
excoriations	O
on	O
arms.	O
R.	O
PICC	O
in	O
place.	O
Pertinent	O
Results:	O
ADMISSION:	O
----------	O
___	O
06:15PM	O
BLOOD	O
WBC-7.7	O
RBC-2.10*	O
Hgb-6.5*	O
Hct-21.3*	O
MCV-105*	O
MCH-30.7	O
MCHC-29.4*	O
RDW-17.3*	O
Plt	O
___	O
___	O
06:15PM	O
BLOOD	O
Neuts-76.7*	O
Lymphs-16.7*	O
Monos-4.8	O
Eos-1.6	O
Baso-0.2	O
___	O
06:15PM	O
BLOOD	O
___	O
PTT-28.3	O
___	O
___	O
06:15PM	O
BLOOD	O
Glucose-97	O
UreaN-64*	O
Creat-3.9*	O
Na-140	O
K-6.2*	O
Cl-113*	O
HCO3-13*	O
AnGap-20	O
___	O
03:44AM	O
BLOOD	O
ALT-23	O
AST-23	O
AlkPhos-97	O
TotBili-0.3	O
___	O
10:53PM	O
BLOOD	O
CK(CPK)-226	O
___	O
10:53PM	O
BLOOD	O
Calcium-7.9*	O
Phos-4.3	O
Mg-2.7*	O
___	O
06:30PM	O
BLOOD	O
Glucose-80	O
Lactate-1.7	O
Na-139	O
K-6.1*	O
Cl-120*	O
calHCO3-14*	O
PERTINENT	O
RESULTS:	O
------------------	O
___	O
09:00AM	O
BLOOD	O
Ret	O
Aut-3.4*	O
___	O
10:53PM	O
BLOOD	O
CK-MB-9	O
cTropnT-0.06*	O
___	O
03:44AM	O
BLOOD	O
ALT-23	O
AST-23	O
AlkPhos-97	O
TotBili-0.3	O
___	O
09:00AM	O
BLOOD	O
Folate-12.4	O
___	O
04:33PM	O
BLOOD	O
Hapto-281*	O
DISCHARGE	O
LABS:	O
---------------	O
___	O
05:00AM	O
BLOOD	O
WBC-8.4	O
RBC-2.28*	O
Hgb-7.1*	O
Hct-23.8*	O
MCV-105*	O
MCH-31.1	O
MCHC-29.8*	O
RDW-17.6*	O
Plt	O
___	O
___	O
06:15PM	O
BLOOD	O
Neuts-76.7*	O
Lymphs-16.7*	O
Monos-4.8	O
Eos-1.6	O
Baso-0.2	O
___	O
09:00AM	O
BLOOD	O
Ret	O
Aut-3.4*	O
___	O
05:00AM	O
BLOOD	O
Glucose-114*	O
UreaN-51*	O
Creat-4.2*	O
Na-144	O
K-4.3	O
Cl-109*	O
HCO3-23	O
AnGap-16	O
IMAGING:	O
--------	O
___	O
CXR:	O
Pulmonary	O
edema	O
now	O
involves	O
all	O
of	O
both	O
lungs,	O
moderately	O
severe	O
throughout.	O
Aeration	O
in	O
the	O
lower	O
lobes	O
has	O
improved	O
minimally.	O
Moderate-to-severe	O
cardiomegaly	O
and	O
mediastinal	O
vascular	O
engorgement	O
both	O
worsened	O
compared	O
to	O
___.	O
Bilateral	O
pleural	O
effusion	O
is	O
presumed,	O
could	O
be	O
substantial	O
on	O
the	O
right.	O
No	O
pneumothorax.	O
___	O
abdominal	O
XR:	O
There	O
is	O
a	O
non-specific	O
bowel	O
gas	O
pattern	O
with	O
no	O
evidence	O
of	O
obstruction.	O
There	O
are	O
no	O
radiopaque	O
foreign	O
bodies.	O
There	O
are	O
no	O
acute	O
fractures	O
or	O
dislocations.	O
IMPRESSION:	O
No	O
evidence	O
of	O
obstruction.	O
___	O
ECHO:	O
The	O
left	O
atrial	O
volume	O
is	O
severely	O
increased.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
at	O
least	O
15	O
mmHg.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
normal	O
cavity	O
size	O
and	O
regional/global	O
systolic	O
function	O
(LVEF>55%).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
ascending	O
aorta	O
is	O
mildly	O
dilated.	O
A	O
bioprosthetic	O
aortic	O
valve	O
prosthesis	O
is	O
present	O
without	O
evidence	O
of	O
valve	O
dehiscence.	O
The	O
prosthetic	O
aortic	O
valve	O
leaflets	O
appear	O
normal	O
The	O
transaortic	O
gradient	O
is	O
higher	O
than	O
expected	O
for	O
this	O
type	O
of	O
prosthesis.	O
A	O
paravalvular	O
aortic	O
valve	O
leak	O
is	O
probably	O
present.	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
Mild	O
to	O
moderate	O
(___)	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
Significant	O
pulmonic	O
regurgitation	O
is	O
seen.	O
There	O
is	O
a	O
very	O
small	O
pericardial	O
effusion.	O
Compared	O
with	O
the	O
prior	O
study	O
(images	O
reviewed)	O
of	O
___,	O
transaortic	O
gradients	O
are	O
higher	O
with	O
similar	O
degree	O
of	O
paravalvular	O
leak.	O
There	O
is	O
more	O
mitral	O
regurgitation.	O
Pulmonary	O
pressures	O
are	O
significantly	O
higher.	O
Other	O
findings	O
are	O
similar.	O
___	O
CXR:	O
As	O
compared	O
to	O
the	O
previous	O
radiograph,	O
there	O
is	O
a	O
reoccurrence	O
of	O
the	O
pre-existing	O
pulmonary	O
edema.	O
The	O
image	O
resembles	O
___.	O
Again,mild	O
blunting	O
of	O
the	O
costophrenic	O
sinuses	O
is	O
seen,	O
right	O
more	O
than	O
left,	O
suggesting	O
coexisting	O
mild	O
pleural	O
effusion.	O
Moderate	O
cardiomegaly,	O
stable	O
appearance	O
of	O
the	O
sternal	O
wires,	O
the	O
valvular	O
replacement,	O
and	O
the	O
right	O
PICC	O
line.	O
MICRO:	O
URINE	O
CULTURE	O
(Final	O
___:	O
PROTEUS	O
MIRABILIS.	O
10,000-100,000	O
ORGANISMS/ML..	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
PROTEUS	O
MIRABILIS	O
|	O
AMPICILLIN------------	O
=>32	O
R	O
AMPICILLIN/SULBACTAM--	O
<=2	O
S	O
CEFAZOLIN-------------	O
8	O
R	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------	O
2	O
I	O
GENTAMICIN------------	O
<=1	O
S	O
MEROPENEM-------------	O
1	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
TOBRAMYCIN------------	O
<=1	O
S	O
TRIMETHOPRIM/SULFA----	O
=>16	O
R	O
Brief	O
Hospital	O
Course:	O
___	O
with	O
PMHx	O
of	O
CKD,	O
CAD	O
(s/p	O
CABG),	O
AS	O
(sp	O
AVR),	O
HTN,	O
recurrent	O
UTI	B-Urinary_tract_infection
___	O
urinary	O
obstruction	O
and	O
BPH(s/p	O
TURP)	O
presents	O
from	O
his	O
living	O
center	O
with	O
improving	O
respiratory	O
distress,	O
anemia	O
s/p	O
1U	O
PRBCs,	O
hyperkalemia	O
and	O
___.	O
ACUTE	O
ISSUES:	O
==============	O
#	O
Respiratory	O
distress:	O
The	O
patient	O
presented	O
with	O
dyspnea	O
and	O
CXR	O
consistent	O
with	O
pulmonary	O
edema.	O
His	O
volume	O
overload	O
was	O
most	O
likely	O
due	O
to	O
diastolic	O
HF	O
with	O
preserved	O
EF	O
exacerbated	O
by	O
volume	O
overload	O
from	O
acutely	O
decompensated	O
CKD.	O
An	O
ECHO	O
showed	O
severe	O
dilation	O
of	O
the	O
left	O
atrium,	O
elevated	O
pulmonary	O
pressures,	O
and	O
preserved	O
systolic	O
function.	O
His	O
dyspnea	O
resolved	O
after	O
receiving	O
60-120	O
mg	O
of	O
IV	O
furosemide	O
with	O
metolazone	O
daily	O
for	O
three	O
days.	O
He	O
was	O
then	O
restarted	O
on	O
torsemide,	O
with	O
the	O
dose	O
increased	O
to	O
10	O
mg	O
from	O
his	O
home	O
dose	O
of	O
5	O
mg.	O
On	O
this	O
increased	O
dose,	O
pt	O
was	O
able	O
to	O
maintain	O
I/O's	O
roughly	O
even.	O
#	O
Hyperkalemia:	O
The	O
patient's	O
K	O
on	O
admission	O
was	O
elevated	O
at	O
6.1	O
without	O
EKG	O
changes	O
in	O
the	O
setting	O
of	O
worsening	O
renal	O
function.	O
He	O
was	O
successfully	O
treated	O
for	O
hyperkalemia	O
with	O
D50,	O
insulin,	O
calcium	O
gluconate,	O
and	O
IV	O
lasix	O
diuresis.	O
He	O
was	O
then	O
re-started	O
on	O
torsemide	O
at	O
10	O
mg	O
per	O
day.	O
On	O
discharge,	O
his	O
K	O
was	O
stable	O
at	O
4.3.	O
#	O
Acute	O
on	O
Chronic	O
kidney	O
disease:	O
The	O
patient	O
has	O
had	O
a	O
progressive	O
decline	O
in	O
renal	O
function,	O
and	O
presented	O
to	O
___	O
with	O
a	O
Cr	O
of	O
3.9	O
from	O
baseline	O
3.1.	O
In	O
discussion	O
with	O
his	O
primary	O
nephrologist,	O
it	O
was	O
determined	O
that	O
pt	O
was	O
not	O
a	O
candidate	O
for	O
dialysis	O
due	O
to	O
declining	O
cognitive	O
function.	O
This	O
was	O
reiterated	O
in	O
conversations	O
with	O
nephrology	O
and	O
with	O
the	O
patient's	O
son	O
during	O
this	O
visit.	O
The	O
patient	O
was	O
continued	O
on	O
his	O
home	O
bicarb	O
and	O
maintained	O
on	O
a	O
renal	O
diet.	O
Of	O
note,	O
pt	O
responded	O
to	O
diuresis	O
well	O
during	O
his	O
hospital	O
course	O
and	O
continued	O
to	O
have	O
normal	O
range	O
urine	O
output.	O
#	O
CA-UTI:	B-Urinary_tract_infection
The	O
patient's	O
urine	O
on	O
admission	O
grew	O
proteus,	O
sensitive	O
to	O
ceftriaxone.	O
The	O
patient	O
was	O
asymptomatic,	O
but	O
he	O
was	O
treated	O
given	O
his	O
multiple	O
comorbidities.	O
He	O
received	O
ceftriaxone	O
1g	O
q24h	O
and	O
completed	O
a	O
___nemia:	O
The	O
patient's	O
hematocrit	O
on	O
admission	O
was	O
18,	O
down	O
from	O
a	O
baseline	O
of	O
approximately	O
___.	O
His	O
hematocrit	O
bumped	O
to	O
___	O
after	O
1U	O
PRBCs	O
and	O
remained	O
stable	O
after	O
that	O
time.	O
Further	O
work-up	O
of	O
his	O
anemia	O
revealed	O
relative	O
reticulocytopenia,	O
normal	O
thyroid	O
function,	O
normal	O
LFTs,	O
normal	O
B12/folate.	O
In	O
the	O
absence	O
of	O
these	O
sources	O
of	O
macrocytic	O
anemia,	O
myelodysplastic	O
syndrome	O
is	O
a	O
possible	O
etiology.	O
We	O
did	O
not	O
do	O
further	O
work-up	O
given	O
goals	O
of	O
care	O
as	O
discussed	O
with	O
the	O
patient's	O
son,	O
who	O
is	O
his	O
HCP.	O
He	O
was	O
hemodynamically	O
stable	O
throughout	O
his	O
admission.	O
CHRONIC	O
ISSUES:	O
==============	O
#	O
HTN:	O
The	O
patient	O
was	O
continued	O
on	O
his	O
home	O
metoprolol	O
and	O
amlodipine.	O
#	O
CAD	O
s/p	O
CABG	O
w/	O
AVR:	O
The	O
patient	O
was	O
continued	O
on	O
his	O
home	O
atorvastatin	O
and	O
metoprolol.	O
#	O
Hyperlipidemia:	O
The	O
patient	O
was	O
continued	O
on	O
his	O
home	O
atorvastatin.	O
#	O
Constipation:	B-Constipation
Patient	O
was	O
treated	O
with	O
miralax,	O
docusate,	O
senna,	O
and	O
bisacodyl.	O
#	O
GOUT:	O
The	O
patient's	O
home	O
renally	O
dosed	O
allopurinol	O
was	O
held	O
during	O
this	O
admission.	O
He	O
had	O
no	O
gout	O
flare	O
during	O
this	O
admission.	O
On	O
discharge,	O
pt's	O
allopurinol	O
was	O
restarted.	O
#	O
Seizure	B-Seizures
disorder:	O
Previous	O
discharge	O
summaries	O
mentioned	O
a	O
seizure	B-Seizures
in	O
the	O
setting	O
of	O
taking	O
ertepenem.	O
The	O
patient	O
was	O
briefly	O
on	O
Keppra	O
but	O
is	O
no	O
longer	O
taking	O
this	O
medication.	O
He	O
had	O
no	O
seizure	B-Seizures
activity	O
while	O
inpatient.	O
TRANSITIONAL	O
ISSUES:	O
====================	O
#	O
Subacute	O
Hct	O
drop:	O
The	O
patient's	O
hct	O
on	O
admission	O
was	O
18,	O
down	O
from	O
___	O
at	O
baseline.	O
Occult	O
GIB	B-Lower_gastrointestinal_haemorrhage
is	O
a	O
possible	O
etiology	O
for	O
his	O
subacute	O
drop	O
in	O
Hct,	O
as	O
his	O
stool	O
was	O
guiac	O
positive	O
at	O
an	O
OSH.	O
He	O
had	O
no	O
evidence	O
of	O
ongoing	O
bleed	O
while	O
inpatient.	O
___	O
consider	O
further	O
GI	O
work-up	O
as	O
an	O
outpatient.	O
#	O
Volume	O
status:	O
The	O
patient's	O
torsemide	O
was	O
increased	O
to	O
10	O
mg	O
(from	O
5)	O
during	O
this	O
admission	O
given	O
his	O
persistent	O
hypervolemia.	O
It	O
will	O
be	O
important	O
to	O
monitor	O
his	O
weight	O
and	O
in's	O
and	O
out's	O
on	O
this	O
new	O
dose	O
to	O
ensure	O
that	O
he	O
is	O
adequately	O
diuresed	O
while	O
still	O
maintaining	O
sufficient	O
volume	O
to	O
perfuse	O
his	O
kidney.	O
In	O
general,	O
his	O
daily	O
in's	O
and	O
out's	O
should	O
be	O
approximately	O
equal.	O
#	O
Goals	O
of	O
care:	O
We	O
spoke	O
extensively	O
with	O
Mr.	O
___	O
son	O
about	O
goals	O
of	O
care.	O
He	O
is	O
aware	O
that	O
his	O
father's	O
renal	O
disease	O
is	O
end-stage.	O
He	O
reaffirmed	O
that	O
his	O
father	O
would	O
not	O
undergo	O
dialysis.	O
His	O
primary	O
goal	O
is	O
his	O
father's	O
___,	O
and	O
he	O
would	O
like	O
the	O
patient	O
to	O
avoid	O
hospitalization	O
whenever	O
possible.	O
Ongoing	O
conversations	O
with	O
providers	O
at	O
Mr.	O
___	O
___	O
about	O
goals	O
of	O
care,	O
as	O
well	O
as	O
discussion	O
of	O
indications	O
for	O
hospitalizations	O
within	O
these	O
goals	O
of	O
care,	O
will	O
be	O
useful.	O
#	O
Transportation	O
to	O
___:	O
The	O
patient's	O
son	O
would	O
like	O
to	O
move	O
him	O
to	O
___,	O
and	O
he	O
has	O
begun	O
to	O
research	O
nursing	O
facilities.	O
The	O
son	O
will	O
need	O
assistance	O
in	O
coordinating	O
transit	O
to	O
___	O
once	O
he	O
has	O
found	O
an	O
appropriate	O
facility	O
for	O
Mr.	O
___.	O
#	O
Allopurinol	O
was	O
restarted	O
at	O
discharge,	O
please	O
montior	O
renal	O
function	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
BID	O
2.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
3.	O
HydrOXYzine	O
25	O
mg	O
PO	O
Q6H:PRN	O
itch	O
4.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
PO	O
DAILY	O
5.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
constipation	B-Constipation
6.	O
Cholestyramine	O
8	O
gm	O
PO	O
QHS	O
7.	O
Sodium	O
Bicarbonate	O
1300	O
mg	O
PO	O
BID	O
8.	O
Torsemide	O
5	O
mg	O
PO	O
DAILY	O
9.	O
TraZODone	O
25	O
mg	O
PO	O
HS:PRN	O
insomnia	O
10.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Ointment	O
1	O
Appl	O
TP	O
BID:PRN	O
rash	O
11.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
pain	O
12.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
BID	O
13.	O
Vitamin	O
D	O
50,000	O
UNIT	O
PO	O
1X/WEEK	O
(___)	O
14.	O
Allopurinol	O
___	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
15.	O
Amlodipine	O
10	O
mg	O
PO	O
HS	O
16.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
17.	O
Atorvastatin	O
40	O
mg	O
PO	O
DAILY	O
18.	O
Calcium	O
Acetate	O
667	O
mg	O
PO	O
BID	O
19.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
pain	O
2.	O
Amlodipine	O
10	O
mg	O
PO	O
HS	O
3.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
BID	O
4.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
5.	O
Atorvastatin	O
40	O
mg	O
PO	O
DAILY	O
6.	O
Calcium	O
Acetate	O
667	O
mg	O
PO	O
BID	O
7.	O
Cholestyramine	O
8	O
gm	O
PO	O
QHS	O
8.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
9.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
BID	O
10.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
PO	O
DAILY	O
11.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
BID	O
constipation	B-Constipation
12.	O
Sodium	O
Bicarbonate	O
1300	O
mg	O
PO	O
BID	O
13.	O
Tamsulosin	O
0.4	O
mg	O
PO	O
HS	O
14.	O
Torsemide	O
10	O
mg	O
PO	O
DAILY	O
15.	O
Triamcinolone	O
Acetonide	O
0.1%	O
Ointment	O
1	O
Appl	O
TP	O
BID:PRN	O
rash	O
16.	O
Vitamin	O
D	O
50,000	O
UNIT	O
PO	O
1X/WEEK	O
(___)	O
17.	O
Sarna	O
Lotion	O
1	O
Appl	O
TP	O
TID:PRN	O
Itch	O
18.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
Constipation	O
19.	O
Bisacodyl	O
10	O
mg	O
PO	O
DAILY	O
constipation	O
20.	O
TraZODone	O
25	O
mg	O
PO	O
HS:PRN	O
insomnia	O
21.	O
HydrOXYzine	O
25	O
mg	O
PO	O
Q6H:PRN	O
itch	O
22.	O
Allopurinol	O
___	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
Primary	O
diagnoses:	O
#	O
Acute	O
on	O
chronic	O
kidney	O
injury	O
#	O
Hyperkalemia	O
#	O
Pulmonary	O
edema	O
#	O
Proteus	O
UTI	B-Urinary_tract_infection
Secondary	O
diagnoses:	O
#	O
Macrocytic	O
anemia	O
#	O
Diastolic	O
HF	O
#	O
Hypertension	O
#	O
Hyperlipidemia	O
#	O
Gout	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Unspecified_cognitive_impairment
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	O
of	O
Bed	O
with	O
assistance	O
to	O
chair	B-Bed_Chairbound
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
It	O
was	O
a	O
pleasure	O
to	O
care	O
for	O
you	O
at	O
___.	O
You	O
were	O
admitted	O
with	O
high	O
potassium,	O
low	O
blood	O
counts,	O
and	O
difficulty	O
breathing.	O
Your	O
difficulty	O
breathing	O
was	O
most	O
likely	O
due	O
to	O
extra	O
fluid	O
in	O
your	O
lungs	O
resulting	O
from	O
your	O
renal	O
disease.	O
We	O
treated	O
you	O
with	O
diuretics	O
which	O
help	O
you	O
urinate.	O
This	O
improved	O
your	O
breathing.	O
We	O
also	O
gave	O
you	O
several	O
medications	O
that	O
lower	O
your	O
potassium.	O
You	O
also	O
received	O
a	O
blood	O
transfusion	O
to	O
help	O
increase	O
your	O
blood	O
count.	O
Finally,	O
you	O
were	O
treated	O
with	O
a	O
short	O
course	O
of	O
antibiotics	O
for	O
a	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
Please	O
call	O
your	O
doctor	O
if	O
your	O
breathing	O
worsens,	O
you	O
develop	O
ankle	O
swelling,	O
or	O
you	O
gain	O
greater	O
than	O
3	O
pounds.	O
We	O
are	O
increasing	O
your	O
home	O
dose	O
of	O
Torsemide	O
to	O
10	O
mg	O
to	O
help	O
prevent	O
you	O
from	O
retaining	O
extra	O
fluid	O
and	O
developing	O
breathing	O
difficulties.	O
We	O
wish	O
you	O
all	O
the	O
best,	O
Your	O
___	O
team	O
Followup	O
Instructions:	O
___	O

